Comparative Immunogenicity Study of Two Hepatitis A Vaccines
NCT ID: NCT03231605
Last Updated: 2017-08-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
300 participants
INTERVENTIONAL
2017-07-26
2017-12-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines
NCT02601040
Immunogenicity and Safety of Hepatitis A Among People Aged 18-50 Years Old
NCT06058416
Immunogenicity of Hepatitis B Vaccination in HIV-infected Adults
NCT03316807
A Clinical Trial to Evaluate a Recombinant Hepatitis E Vaccine in Healthy Adults
NCT02603055
Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-treatment Patients With Chronic Hepatitis C：An Open-label Control Study in China
NCT02898922
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Group 1 is experimental group which used the Hepatitis A Vaccine product by Changchun Institute of Biological Co.,Ltd
Hepatitis A Vaccine
Vaccinating two Hepatitis A Vaccines separately in 18-24 months Children based on the grouping result .
Group 2
Group 2 is control group which used the Hepatitis A Vaccine product by Changchun Changsheng Life Sciences Limited
Hepatitis A Vaccine
Vaccinating two Hepatitis A Vaccines separately in 18-24 months Children based on the grouping result .
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hepatitis A Vaccine
Vaccinating two Hepatitis A Vaccines separately in 18-24 months Children based on the grouping result .
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No Hepatitis A disease and contraindication of vaccination
* No history of Hepatitis A Vaccine
* The subjects can follow the requirements of experiment project.
* Do not vaccinate other vaccine in one months.
* Axillary's temperature≤37℃
* Have a serious chronic disease
* Any conditions which researcher think will influence the results or the subjects.
Exclusion Criteria
* Allergy to the components in Vaccine
* Immune abnormalities
18 Months
24 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shaanxi Provincial Center for Disease Control and Prevention
OTHER
China National Biotec Group Company Limited
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanxi Provincial Center for Disease Control and Prevention
Yuncheng, Shanxi, China
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
91110000100010062X
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.